These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 12214268

  • 21. The human p73 promoter: characterization and identification of functional E2F binding sites.
    Seelan RS, Irwin M, van der Stoop P, Qian C, Kaelin WG, Liu W.
    Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839
    [Abstract] [Full Text] [Related]

  • 22. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 23. The role of the transcription factor DP in apoptosis.
    Hitchens MR, Robbins PD.
    Apoptosis; 2003 Oct 25; 8(5):461-8. PubMed ID: 12975577
    [Abstract] [Full Text] [Related]

  • 24. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53.
    Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, Abraham N, Bell JC, Koromilas AE.
    Mol Cell Biol; 1999 Apr 25; 19(4):2475-84. PubMed ID: 10082513
    [Abstract] [Full Text] [Related]

  • 25. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
    Ozono E, Komori H, Iwanaga R, Tanaka T, Sakae T, Kitamura H, Yamaoka S, Ohtani K.
    Genes Cells; 2012 Aug 25; 17(8):660-72. PubMed ID: 22702391
    [Abstract] [Full Text] [Related]

  • 26. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F.
    Oncogene; 2008 Sep 11; 27(40):5303-14. PubMed ID: 18521084
    [Abstract] [Full Text] [Related]

  • 27. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
    Fogal V, Hsieh JK, Royer C, Zhong S, Lu X.
    EMBO J; 2005 Aug 03; 24(15):2768-82. PubMed ID: 16037820
    [Abstract] [Full Text] [Related]

  • 28. ATM is a target for positive regulation by E2F-1.
    Berkovich E, Ginsberg D.
    Oncogene; 2003 Jan 16; 22(2):161-7. PubMed ID: 12527885
    [Abstract] [Full Text] [Related]

  • 29. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL, Dong YB, Elliott MJ, Liu TJ, Atienza C, Stilwell A, McMasters KM.
    Clin Cancer Res; 1999 Aug 16; 5(8):2242-50. PubMed ID: 10473112
    [Abstract] [Full Text] [Related]

  • 30. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ, Dong YB, Yang H, McMasters KM.
    Clin Cancer Res; 2001 Nov 16; 7(11):3590-7. PubMed ID: 11705881
    [Abstract] [Full Text] [Related]

  • 31. The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.
    Bennett RL, Pan Y, Christian J, Hui T, May WS.
    Cell Cycle; 2012 Jan 15; 11(2):407-17. PubMed ID: 22214662
    [Abstract] [Full Text] [Related]

  • 32. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.
    La Sala D, Macaluso M, Trimarchi C, Giordano A, Cinti C.
    Oncogene; 2003 Jun 05; 22(23):3518-29. PubMed ID: 12789260
    [Abstract] [Full Text] [Related]

  • 33. HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway.
    Finzer P, Krueger A, Stöhr M, Brenner D, Soto U, Kuntzen C, Krammer PH, Rösl F.
    Oncogene; 2004 Jun 17; 23(28):4807-17. PubMed ID: 15077164
    [Abstract] [Full Text] [Related]

  • 34. Oncogenes induce and activate endogenous p73 protein.
    Zaika A, Irwin M, Sansome C, Moll UM.
    J Biol Chem; 2001 Apr 06; 276(14):11310-6. PubMed ID: 11115495
    [Abstract] [Full Text] [Related]

  • 35. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q, Liang D, Yang T, Leone G, Overbeek PA.
    Dev Neurosci; 2004 Apr 06; 26(5-6):435-45. PubMed ID: 15855772
    [Abstract] [Full Text] [Related]

  • 36. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M, Berberich SJ.
    Oncogene; 2002 Jun 27; 21(28):4414-21. PubMed ID: 12080472
    [Abstract] [Full Text] [Related]

  • 37. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM.
    Clin Cancer Res; 2000 Apr 27; 6(4):1579-89. PubMed ID: 10778992
    [Abstract] [Full Text] [Related]

  • 38. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 27; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 39. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN, Pant V.
    DNA Cell Biol; 1999 Dec 27; 18(12):911-22. PubMed ID: 10619603
    [Abstract] [Full Text] [Related]

  • 40. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A.
    Nat Cell Biol; 2001 Jan 27; 3(1):1-7. PubMed ID: 11146619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.